logo

For the Inventor, By the Inventor

Philadelphia, PA, United States of America

Enterin, Inc.

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 10.0


Forward Citations = 1

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Michael A Zasloff (9 out of 56 patents)

silverMedal Denise Barbut (4 out of 5 patents)

bronzeMedal Qi Gao (1 out of 1 patent)

4.  Giovanna Brancatelli (1 out of 1 patent)

5.  William A Kinney (1 out of 1 patent)

6.  Anil Kumar (1 out of 1 patent)

7.  Eric Chellquist (1 patent)

8.  Mary Doubleday (1 patent)

9.  Charles Gilbert (1 patent)

10.  Xuehai Zhang (1 patent)

11.  Michael McLane (2 patents)

12.  Kyle Armbruster (1 patent)

13.  Roy Clifford Levitt (23 patents)

14.  Kyle Ambruster (0 patent)


10 patents:

1. 12686699 - Crystalline forms of squalamine (2026-07-21),
2. 12503485 - Human aminosterol ENT-03 compounds, related compositions comprising the same, and methods of using the same (2025-12-23),
3. 11464789 - Aminosterol compositions and methods of using the same for treating schizophrenia (2022-10-11),
4. 11440936 - Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same (2022-09-13),
5. 11419879 - Methods for treating and preventing viral infections (2022-08-23),
6. 11083735 - Methods for treating sleep disorders, sleep disturbances, and related symptoms using aminosterol compositions (2021-08-10),
7. 11066438 - Squalamine solid forms and methods of making the same (2021-07-20),
8. 10975116 - Methods of treating and preventing gastrointestinal motility disorders using aminosterols (2021-04-13),
9. 10633413 - Methods of treating Parkinson's disease using aminosterols and compositions comprising the same (2020-04-28),
10. 10478444 - Methods and compositions for treating and preventing viral infections (2019-11-19),
Company Overview
Enterin, Inc. is a biotechnology company based in Philadelphia, PA, focused on developing innovative therapies for neurodegenerative diseases. The company specializes in leveraging its proprietary drug delivery technology to enhance the treatment of conditions such as Parkinson's disease. Enterin's research emphasizes the intersection of neurology and pharmacology, aiming to improve patient outcomes through targeted therapeutic approaches. With a commitment to advancing medical science, Enterin is dedicated to addressing unmet needs in the field of neurodegeneration.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Enterin, Inc. USPTO Patent Assignee Logo
10 Patents

#99 in Philadelphia, PA

#1,085 in Pennsylvania

#29,892 in US

#56,119 in the World

Philadelphia, PA (US)
Philadelphia, PA, United States of America

Enterin, Inc.

Forward Citations = 1

6 inventors:

goldMedal Michael A Zasloff (9 out of 56 patents)

silverMedal Denise Barbut (4 out of 5 patents)

bronzeMedal Qi Gao (1 out of 1 patent)

4.  Giovanna Brancatelli (1 out of 1 patent)

5.  William A Kinney (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Enterin, Inc.. Retrieved from https://idiyas.com/company/enterin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…